Pseudoaphakia Clinical Trial
Official title:
A Single-Center, Open-Label, Randomized Clinical Study Measuring Time Needed for Testing Between the Haag-Streit Lenstar 900 Version i4 and the Carl Zeiss IOL Master 500 Instruments
Verified date | July 2012 |
Source | Haag Streit USA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objectives of this study are to determine the time needed to complete a full set of measurements (Total Ophthalmic Exam, Subject Data Entry and Acquisition of the Measurement) by each test device, the Lenstar 900 Version i4 and IOL Master 500.
Status | Completed |
Enrollment | 61 |
Est. completion date | March 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Subjects wbo meet all of the following criteria are eligible to participate in tbe study: 1. Male or female l8 years of age or older on the date of Informed Consent. 2. At least one eye of each subject must be a phakic eye. 3. Subject must be able to fixate on a target. 4. Able to understand and willing to sign tbe informed consent. Exclusion Criteria: Subjects will be excluded from the study if the following applies: 1. History of corneal surgery. 2. Use of contact lenses during tbe ophthalmic exam or up to two hours prior to the exam. 3. Any ophthalmic condition preventing use of either of the instruments used in the study. 4. Any ophthalmic condition which might impair tbe validity of results from any of the instruments used in the study. 5. Any medical condition, which, in tbe Investigator's judgment, interferes with the subjects ability to comply with tbe protocol, compromises subject safety, or interferes with tbe interpretation of the study results. |
Country | Name | City | State |
---|---|---|---|
United States | Cincinnati Eye Institute | Cincinnati | Ohio |
Lead Sponsor | Collaborator |
---|---|
Haag Streit USA |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to complete a full examination | Time to complete a full ophthalmic exam(as measured from the time of subject placement just prior to the technician completing data entry at the test product, to the beginning of data printing) for each, the IOL Master 500 and the Haag-Streit Lenstar Version i4. | At Study Visit (study consists of 1 visit only) | |
Secondary | Data Entry Time Measurement | Additional Time Measurements - Data Entry from the IOL Master 500 and the Haag-Streit Lenstar Version i4. | At Study Visit (study consists of 1 visit only) | |
Secondary | Measurement Acquisition Time Measurement | Additional Timed Measurements - Measurement Acquisition from the IOL Master 500 and the Haag-Streit Lenstar Version i4. | At Study Visit (study consists of 1 visit only) | |
Secondary | Adverse Events | Any adverse events associated with the test products | Duration of study from signing informed consent to Study Visit (study consists of 1 visit only) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04224129 -
Characterization and Causative Factors of Negative Dysphotopsia
|
||
Completed |
NCT02138123 -
Intraocular Lens-shell Technique in Phacoemulsification
|
N/A |